<DOC>
	<DOC>NCT02569775</DOC>
	<brief_summary>The aim of this study is to assess the safety and effectiveness of autologous bone marrow mononuclear stem cells in patients with cerebral palsy.</brief_summary>
	<brief_title>Outcomes of Stem Cells for Cerebral Palsy</brief_title>
	<detailed_description>The aim of this study is to assess the safety and effectiveness of autologous bone marrow mononuclear stem cells in 40 patients with cerebral palsy at Vinmec International Hospital, Hanoi, Vietnam.</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<criteria>Cerebral palsy of any types caused by oxygen deprivation. Epilepsy Hydrocephalus with ventricular drain Coagulation disorders Allergy to anesthetic agents Severe health conditions such as cancer, failure of heart, lung, liver or kidney Active infections</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Cerebral Palsy</keyword>
	<keyword>Stem Cells</keyword>
</DOC>